Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00544) | |||||
---|---|---|---|---|---|
Name |
Potassium citrate
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
Potassium citrate; TRIPOTASSIUM CITRATE; 866-84-2; Potassium citrate anhydrous; 7778-49-6; Potassiumcitrate; Citric acid, tripotassium salt; UNII-86R1NVR0HW; 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, tripotassium salt; 86R1NVR0HW; Kaliksir; CHEBI:64733; Citric acid, potassium salt; tripotassium 2-hydroxypropane-1,2,3-tricarboxylate; tripotassium;2-hydroxypropane-1,2,3-tricarboxylate; Litocit; Porekal; Polycitra K; Urocit K; Seltz-K; C6H5K3O7; K citrate; 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, potassium salt (1:3); Potassium tribasic citrate; tripotassium citrate anhydrous; ACALKA; CCRIS 6566; HSDB 1248; EINECS 212-755-5; Potassium Citrate (anhydrous); EINECS 231-905-0; tri potassium citrate; 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, potassium salt; potassium citrate (anh.); anhydrous potassium citrate; EC 212-755-5; tripotassium citrate (anh.); anhydrous tripotassium citrate; INS NO.332(II); CHEMBL1200458; DTXSID8027325; tripotassium citrate (anhydrous); INS-332(II); 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, potassium salt (1:?); E-332(II); citric acid tripotassium salt (anh.); AKOS015918285; DB09125; citric acid tripotassium salt (anhydrous); FT-0653076; 1334-EP2380568A1; potassium 2-hydroxypropane-1,2,3-tricarboxylate; A841790; Q419921; tripotassium 2-oxidanylpropane-1,2,3-tricarboxylate
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Urinary calculus | ICD-11: GB70 | [1] | ||
PubChem CID | |||||
Formula |
C6H5K3O7
|
||||
Canonical SMILES |
C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[K+].[K+].[K+]
|
||||
InChI |
1S/C6H8O7.3K/c7-3(8)1-6(13,5(11)12)2-4(9)10;;;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;/q;3*+1/p-3
|
||||
InChIKey |
QEEAPRPFLLJWCF-UHFFFAOYSA-K
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=13344"></iframe>
|
||||
3D MOL is unavailable | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 306.39 | Topological Polar Surface Area | 141 | |
XlogP | N.A. | Complexity | 211 | ||
Heavy Atom Count | 16 | Rotatable Bond Count | 2 | ||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 7 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Potassium citrate 10 meq tablet | Click to Show/Hide the Full List of Formulation(s): 3 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Magnesium stearate; Carnauba wax
|
|||||
Dosage Form | Extended Release Oral Tablet | |||||
Company | Vensun Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Magnesium stearate; Carnauba wax
|
|||||
Dosage Form | Extended Release Oral Tablet | |||||
Company | Physicians Total Care | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Carnauba wax
|
|||||
Dosage Form | Extended Release Oral Tablet | |||||
Company | American Health Packaging; Cadila Healthcare; Physicians Total Care; RemedyRepack; Zydus Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Potassium citrate 15 meq tablet | Click to Show/Hide the Full List of Formulation(s): 2 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Magnesium stearate; Carnauba wax
|
|||||
Dosage Form | Extended Release Oral Tablet | |||||
Company | Vensun Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Carnauba wax
|
|||||
Dosage Form | Extended Release Oral Tablet | |||||
Company | Cadila Healthcare; Physicians Total Care; Zydus Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Potassium citrate 5 meq tablet | Click to Show/Hide the Full List of Formulation(s): 2 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Magnesium stearate; Carnauba wax
|
|||||
Dosage Form | Extended Release Oral Tablet | |||||
Company | Vensun Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Carnauba wax
|
|||||
Dosage Form | Extended Release Oral Tablet | |||||
Company | Cadila Healthcare; Zydus Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.